Teenage Smoking Rate Decreased, but E-cigarette Use Increased

Aug.21.2023
Teenage Smoking Rate Decreased, but E-cigarette Use Increased
Teenage smoking rates decline during COVID-19, but e-cigarette use increases, alcohol consumption remains stable, and mental health deteriorates.

According to a recent survey conducted by the Korea Centers for Disease Control and Prevention (KCDC), the overall smoking rate among teenagers has decreased in the past two years since the outbreak of COVID-19. The survey, titled the "17th Youth Health Behavior Survey," collected data from approximately 60,000 students from middle school first grade to high school third grade between August and November last year.

 

The statistics revealed that the smoking and drinking habits of teenagers remained stable in 2020, after experiencing a significant drop compared to 2019, the year before the COVID-19 pandemic. The percentage of teenagers who reported smoking cigarettes for more than one day in the past month was 4.5%, a similar level to the previous year (4.4%), and lower than the pre-pandemic rate of 6.7% in 2019.

 

The KCDC attributed this trend to the increase in remote learning and the decrease in peer gatherings during the pandemic period. However, the use of e-cigarettes increased, with the usage rates of liquid-type e-cigarettes rising from 1.9% to 2.9% in a year, and cartridge-type e-cigarettes increasing from 1.1% to 1.4%.

 

In terms of alcohol consumption, the percentage of teenagers who reported drinking at least one glass in the past 30 days remained the same at 10.7%. The "current drinking rate" also showed no significant increase since it dropped from 15.0% in 2019 to 10.7% in 2020.

 

While the average alcohol consumption rate in the past month decreased slightly from 5.2% in 2020 to 4.9% in 2021, indicating a decline in risky drinking behaviors, the accessibility to purchase tobacco and alcohol increased. The percentage of teenagers who reported that they could easily buy cigarettes or alcohol from convenience stores or shops increased significantly compared to the previous year, with the accessibility rate for cigarette purchases rising from 67.0% to 74.8% and for alcohol purchases from 63.5% to 71.3%.

 

While the percentage of teenagers engaging in regular physical activities increased slightly to 14.6% who participated in at least 60 minutes of physical activity for five or more days a week, the dietary habits did not improve. The percentage of teenagers skipping breakfast for five or more days a week continued to rise, reaching 38.0% in 2021, compared to 27.9% in 2015. Additionally, the percentage of teenagers consuming fruits decreased for the fifth consecutive year, recording 18.1% in 2021.

 

Mental health indicators also worsened in 2021 compared to the previous year. The prevalence of depression increased from 25.2% in 2020 to 26.8%, and the perceived stress rate rose from 34.2% to 38.8%. Females showed higher rates of depression (31.4%) and stress (45.6%) compared to males (22.4% and 32.3% respectively).

 

In conclusion, while the smoking rate among teenagers has decreased during the COVID-19 pandemic, the use of e-cigarettes has increased. Additionally, there has been no significant change in alcohol consumption, but the accessibility to purchase tobacco and alcohol has increased. Furthermore, despite a slight increase in regular physical activity, detrimental dietary habits and worsening mental health indicators are concerning issues among teenagers.


Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Italy and Greece Oppose Ireland’s Nicotine Product Bill, Raising EU Regulatory Concerns
Italy and Greece Oppose Ireland’s Nicotine Product Bill, Raising EU Regulatory Concerns
Italy and Greece have opposed Ireland’s proposed nicotine product regulations, arguing that the measures could affect EU market coordination and the free movement of products. Ireland plans to introduce stricter rules covering nicotine products including vapes and nicotine pouches, with measures involving packaging, marketing and sales controls. The dispute highlights differences among EU member states between stronger public health protections and maintaining regulatory consistency within the bloc’s single market.
Jul.29
Product | PMI Japan Expands ZYN by IQOS Strength Portfolio With Strong Series, Increasing Lineup to 12 Products
Product | PMI Japan Expands ZYN by IQOS Strength Portfolio With Strong Series, Increasing Lineup to 12 Products
Philip Morris Japan (PMJ) has expanded the ZYN by IQOS oral tobacco pouch portfolio in Japan with four new ZYN Strong products, adding a third intensity level alongside the existing Low and Medium ranges. The Strong series first entered selected duty-free channels in Japan on July 1, 2026, before expanding to IQOS stores, the ZYN Online Store and selected tobacco retailers from August 18. The expansion increases the Japanese ZYN by IQOS lineup from eight to 12 products.
Aug.20
Reynolds Seeks to Join Altria Lawsuit Challenging FDA PMTA Rule and Calculation of 180-Day Deadline
Reynolds Seeks to Join Altria Lawsuit Challenging FDA PMTA Rule and Calculation of 180-Day Deadline
Three R.J. Reynolds companies are seeking to intervene in a lawsuit filed by Altria subsidiaries Helix Innovations and NJOY challenging the FDA's 2021 PMTA final rule. The companies dispute how the agency uses Acceptance and Filing reviews and completeness determinations to establish when the Tobacco Control Act's 180-day decision period begins. Reynolds has also linked prolonged PMTA reviews to competition from unauthorized vaping products. The FDA, meanwhile, has been accelerating reviews and reducing its backlog.
Sep.14
As JUUL2 Wins FDA Authorization, Harm Reduction Journal Highlights the Role of Real-World Evidence in Nicotine Product Regulation
As JUUL2 Wins FDA Authorization, Harm Reduction Journal Highlights the Role of Real-World Evidence in Nicotine Product Regulation
A commentary published in the international open-access, peer-reviewed Harm Reduction Journal argues that randomized controlled trials remain central to evaluating smoking cessation efficacy but cannot alone capture real-world uptake, complete switching, longer-term use and population impact of non-combustible nicotine products such as e-cigarettes, heated tobacco and nicotine pouches. The authors frame impact as “reach × efficacy” and call for real-world evidence to complement RCTs. Three days after publication, the FDA authorized three JUUL2 products and highlighted complete switching among adult smokers in explaining its decision, providing a timely regulatory backdrop to the debate.
Sep.08
Product | JT Refreshes Ploom CUBE Design and Expands Japan Retail Distribution, Targeting Younger Men and Female Users
Product | JT Refreshes Ploom CUBE Design and Expands Japan Retail Distribution, Targeting Younger Men and Female Users
Japan Tobacco (JT) launched a refreshed Ploom CUBE design in Japan on September 8, 2026, with broader convenience-store and tobacco-retail distribution planned from October 13. The updated device retains the existing Rounded Cube form and heating platform while replacing four previous body colors with Pebble White and Cobalt Black. JT is also introducing new Front Panels and Fabric Back Covers, although the new accessories are not compatible with the previous Ploom CUBE design. The company says the update is intended to broaden appeal among younger male and female users.
Sep.09
IQOS Global Flagship Space to Open in Tokyo Ginza as PMI Expands Consumer Experience Strategy
IQOS Global Flagship Space to Open in Tokyo Ginza as PMI Expands Consumer Experience Strategy
Philip Morris Japan (PMJ) announced that it will open “IQOS Flagship Ginza” in Tokyo on September 4, 2026. The location will become the first global flagship space for PMI’s IQOS brand. PMJ said the venue will target adult smokers aged 20 and above and combine product experiences, community engagement and local cultural elements. The design will incorporate Japanese natural aesthetics and traditional craftsmanship. The launch reflects PMI’s broader strategy of strengthening consumer engagement through experiential retail and brand spaces. The existing IQOS Store Ginza is scheduled to close on August 30, 2026.
Jul.21